Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors at 3 institutions in 1 country.
Fei XieBeijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Department of Nuclear Medicine, Peking Union Medical College Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Science and Peking Union Medical College (PUMC), Beijing, China.
Kun ZhengBeijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Department of Nuclear Medicine, Peking Union Medical College Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Science and Peking Union Medical College (PUMC), Beijing, China.
Linwen LiuBeijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Department of Nuclear Medicine, Peking Union Medical College Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Science and Peking Union Medical College (PUMC), Beijing, China.
Xiaona JinBeijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Department of Nuclear Medicine, Peking Union Medical College Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Science and Peking Union Medical College (PUMC), Beijing, China.
Lilan FuNanfang PET Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zhaohui ZhuBeijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Department of Nuclear Medicine, Peking Union Medical College Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Science and Peking Union Medical College (PUMC), Beijing, China.
Peking Union Medical College Hospital · CNSouthern Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Background: This is a pilot study of radiomics based on Methods: We utilized a dataset of 48 patients who participated in Results: Fourteen of the Conclusion:
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A Pilot Study of Radiomics Models Combining Multi-Probe and Multi-Modality Images of · full record | OpenQuestion